Valuation dashboard for Gelteq Limited Ordinary Shares (GELS) with P/E N/A, P/B 0.59, EV/EBITDA -5.67 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.
Analysis Summary
Trailing-twelve-month margins: gross margin 100.0%, operating margin -19.9%, net margin -21.0%.
At the current price of $0.58, GELS has negative trailing earnings (P/E not meaningful) and an ROE of -24.94%. Market capitalisation stands at $5M.
Balance sheet quality for GELS: current ratio of 0.3. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 0.59 |
| EV / EBITDA | -5.67 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-0.28 |
| vs Current Price | -147.9% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| GELS | Gelteq Limited Ordinary Shares | $5M | 0.59 | -24.9% | |
| TAK | Takeda Pharmaceutical Company Limited | $59.4B | 51.19 | 1.21 | 2.6% |
| TEVA | Teva Pharmaceutical Industries Limited | $45.0B | 61.47 | 5.82 | 17.8% |
| HLN | Haleon plc | $40.5B | 18.64 | 1.84 | 9.9% |
| 0M3Q.L | Zoetis Inc. | $35.4B | |||
| ZTS | Zoetis Inc. | $30.6B | 11.99 | 9.67 | 69.3% |
| HLN.L | Haleon plc | $29.4B | 18.73 | 1.85 | 9.9% |
| 0SAN.L | Sandoz Group AG | $28.3B | 52.81 | 3.84 | 7.0% |
Price
| Price | $0.58 |
| Market Cap | $5M |
| Exchange | NASDAQ |
| Country | AU |
Profitability
| Return on Equity | -24.94% |
| Return on Invested Capital | -18.33% |
| Return on Assets | -18.59% |
| Gross Margin | 100.00% |
| Operating Margin | -1986.04% |
| Net Margin | -2095.34% |
Related companies: AYTU · BFRG · BFRI · BGLC · COCP · EVGN · IMNN
Explore sector: Healthcare · Drug Manufacturers - Specialty & Generic
More sections of GELS: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks